Skip to content
healthcare.dev

Hydroxyprogesterone Caproate

NDC 55150-311, Hydroxyprogesterone Caproate, injection, from Eugia US LLC.

Product NDC
55150-311
Status
Listed
Labeler
Eugia US LLC
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211142
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55150-311 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROXYPROGESTERONE CAPROATE1250 mg/5mL

Pharmacologic classes

Progesterone Congeners [CS]; Progestin [EPC]

Package NDCNDC-11Package
55150-311-01551500311011 VIAL in 1 CARTON (55150-311-01) / 5 mL in 1 VIAL
55150-311-05551500311055 VIAL in 1 CARTON (55150-311-05) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/687bcf42-f437-42c7-8909-a91f621f55df

Use it

Look up 55150-311 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55150-311 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55150-311. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.